Detalhe da pesquisa
1.
Novel second generation analogs of eribulin. Part III: Blood-brain barrier permeability and in vivo activity in a brain tumor model.
Bioorg Med Chem Lett
; 21(6): 1639-43, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21324687
2.
Novel second generation analogs of eribulin. Part II: Orally available and active against resistant tumors in vivo.
Bioorg Med Chem Lett
; 21(6): 1634-8, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21324692
3.
Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term Recovery.
Cancer Res
; 78(3): 817-829, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29191802
4.
Eribulin shows high concentration and long retention in xenograft tumor tissues.
Cancer Chemother Pharmacol
; 80(2): 377-384, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664226
5.
Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61.
Mol Cancer Ther
; 15(6): 1208-16, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27196783
6.
Pharmacokinetic characterization of a natural product-inspired novel MEK1 inhibitor E6201 in preclinical species.
Cancer Chemother Pharmacol
; 69(1): 229-37, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21698359